Andrew Akbashev/X
Nov 11, 2025, 01:48
Andrew Akbashev: Globally, Life in Academia is Getting Worse
Andrew Akbashev, Senior Staff Scientist at PaulScherrer Institute, posted on X:
“Pressure to publish jumps. And researchers have no time to do science. (New survey from Elsevier)
Survey of 3200 researchers:
- Only 45% of scientists have sufficient time for actual research.
- For 68%, the pressure to publish today is greater than 2-3 years ago.
- 29% of researchers are considering relocating to another country (for better funding, work‐life balance, or greater research freedom).
- 58% of researchers use AI tools in their work.
- Reported benefits from AI: saving time (58%), helping with literature summaries (61%), literature reviews (51%), data analysis (38%), drafting proposals (41%), and drafting papers (38%).
Globally, life in academia is getting worse.
For students and postdocs – it’s especially hard to decide on an academic career.
A few days ago, I gave a lecture on this topic.
“PhD: Dreams, Reality and Consequences”
Watch it here:
(I’ll appreciate if you ‘like’ this video – you will GREATLY help it reach more students.)”

Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
